Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.

MLA

Seiler, Sarah, et al. “Associations of FGF-23 and SKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4.” Clinical Journal of the American Society of Nephrology : CJASN, vol. 9, no. 6, June 2014, pp. 1049–58. EBSCOhost, https://doi.org/10.2215/CJN.07870713.

APA

Seiler, S., Rogacev, K. S., Roth, H. J., Shafein, P., Emrich, I., Neuhaus, S., Floege, J., Fliser, D., & Heine, G. H. (2014). Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4. Clinical Journal of the American Society of Nephrology : CJASN, 9(6), 1049–1058. https://doi.org/10.2215/CJN.07870713

Chicago

Seiler, Sarah, Kyrill S Rogacev, Heinz J Roth, Pagah Shafein, Insa Emrich, Stefan Neuhaus, Jürgen Floege, Danilo Fliser, and Gunnar H Heine. 2014. “Associations of FGF-23 and SKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4.” Clinical Journal of the American Society of Nephrology : CJASN 9 (6): 1049–58. doi:10.2215/CJN.07870713.